cannabis-based APIs
Commercial- Indications
- Not specified
Company intelligence / Profile preview
GlobeMed Pharma Group is a privately owned pharmaceutical company specializing in the cultivation of genetically advanced cannabis strains and the production of high-purity cannabinoid APIs. The company operates GACP-certified cultivation facilities in Colombia and Malawi, with manufacturing adhering to EU GMP standards. It pioneers solventless extraction processes for enhanced purity and environmental sustainability while actively developing novel cannabinoid derivatives with improved therapeutic profiles. The group is committed to ongoing clinical validation of its products to improve patient outcomes globally[1][3][10].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GlobeMed Pharma Group.